{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:25:44Z","timestamp":1761157544988,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21576206"],"award-info":[{"award-number":["21576206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Interstitial lung disease (ILD) is a frequently observed comorbidity in autoimmune diseases such as dermatomyositis\/polymyositis (DM\/PM), and it is significantly associated with specific autoantibody types. One unique antibody type is the anti-transcription intermediate factor-1\u03b3 antibody (anti-TIF-1\u03b3 Ab), which has a positive rate of only 7%. It is often found in combination with malignancy and rarely with ILD, particularly rapidly progressive ILD (RPILD). In some cases, the presence of ILD in individuals with DM may indicate a paraneoplastic syndrome. Pneumocystis jiroveci pneumonia (PJP) typically occurs due to intensive immunosuppressive therapy, human immunodeficiency virus (HIV) infection, or malignancy, and rarely as an isolated condition.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 52-year-old man with a history of rapid weight loss but non-HIV infected and not immunosuppressed who presented with fever, cough, dyspnea, weakness of the extremities, characteristic rash and mechanic's hand. Pathogenic tests suggested PJP, laboratory tests suggested a single anti-TIF-1\u03b3 Ab positive DM, imaging suggested ILD, and pathology revealed no malignancy. RPILD and acute respiratory distress syndrome (ARDS) developed after anti-infection and steroid hormone therapy. After mechanical support therapy such as Extracorporeal Membrane Oxygenation (ECMO), the patient developed late-onset cytomegalovirus pneumonia (CMVP), complicated bacterial infection, and ultimately death. Additionally, we discuss the potential causes of rapid weight loss, the mechanisms by which anti-TIF-1\u03b3 Ab may lead to ILD, and the possible connection between anti-TIF-1\u03b3 Ab positivity, rapid weight loss, immune abnormalities, and opportunistic infections.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This case emphasizes the importance of early recognition of malignant tumors and pulmonary lesions, assessment of the body's immune status, prompt initiation of immunosuppressive treatment, and prevention of opportunistic infections in individuals with single anti-TIF-1\u03b3 Ab positive DM presenting with rapid weight loss.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-023-02542-0","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T15:03:13Z","timestamp":1688655793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Rapidly progressive interstitial lung disease combined with pneumocystis jiroveci pneumonia in a patient with single anti-TIF-1\u03b3 antibody positive dermatomyositis in the context of an underlying tumor"],"prefix":"10.1186","volume":"23","author":[{"given":"Hengzhe","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arezou","family":"Bikdeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haipeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"issue":"12","key":"2542_CR1","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, Visser M, et al. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76(12):1955\u201364. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2542_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bjd.18096","volume":"182","author":"JSS Concha","year":"2020","unstructured":"Concha JSS, Pena S, Gaffney RG, Patel B, Tarazi M, Kushner CJ, et al. Developing classification criteria for skin-predominant dermatomyositis: the Delphi process. Br J Dermatol. 2020;182(2):410\u20137. https:\/\/doi.org\/10.1111\/bjd.18096.","journal-title":"Br J Dermatol"},{"key":"2542_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","volume":"101","author":"Z Betteridge","year":"2019","unstructured":"Betteridge Z, Tansley S, Shaddick G, Chinoy H, Cooper RG, New RP, et al. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J Autoimmun. 2019;101:48\u201355. https:\/\/doi.org\/10.1016\/j.jaut.2019.04.001.","journal-title":"J Autoimmun"},{"issue":"3","key":"2542_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jaad.2014.12.009","volume":"72","author":"DF Fiorentino","year":"2015","unstructured":"Fiorentino DF, Kuo K, Chung L, Zaba L, Li S, Casciola-Rosen L. Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1\u03b3 antibodies in adults with dermatomyositis. J Am Acad Dermatol. 2015;72(3):449\u201355. https:\/\/doi.org\/10.1016\/j.jaad.2014.12.009.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2542_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/rheumatology\/kez572","volume":"59","author":"J De Vooght","year":"2020","unstructured":"De Vooght J, Vulsteke JB, De Haes P, Bossuyt X, Lories R, De Langhe E. Anti-TIF1-\u03b3 autoantibodies: warning lights of a tumour autoantigen. Rheumatology (Oxford). 2020;59(3):469\u201377. https:\/\/doi.org\/10.1093\/rheumatology\/kez572.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"2542_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3899\/jrheum.140566","volume":"42","author":"Z Yang","year":"2015","unstructured":"Yang Z, Lin F, Qin B, Liang Y, Zhong R. Polymyositis\/dermatomyositis and malignancy risk: a metaanalysis study. J Rheumatol. 2015;42(2):282\u201391. https:\/\/doi.org\/10.3899\/jrheum.140566.","journal-title":"J Rheumatol"},{"issue":"4","key":"2542_CR7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1046\/j.1365-2133.2001.04140.x","volume":"144","author":"YJ Chen","year":"2001","unstructured":"Chen YJ, Wu CY, Shen JL. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Br J Dermatol. 2001;144(4):825\u201331. https:\/\/doi.org\/10.1046\/j.1365-2133.2001.04140.x.","journal-title":"Br J Dermatol"},{"issue":"Rr-4","key":"2542_CR8","first-page":"1","volume":"58","author":"JE Kaplan","year":"2009","unstructured":"Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(Rr-4):1\u2013207 (quiz CE1-4).","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"2542_CR9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jaad.2009.11.588","volume":"63","author":"JS Lehman","year":"2010","unstructured":"Lehman JS, Kalaaji AN. Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions. J Am Acad Dermatol. 2010;63(5):815\u201323. https:\/\/doi.org\/10.1016\/j.jaad.2009.11.588.","journal-title":"J Am Acad Dermatol"},{"key":"2542_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","volume":"121","author":"H Hozumi","year":"2016","unstructured":"Hozumi H, Fujisawa T, Nakashima R, Johkoh T, Sumikawa H, Murakami A, et al. Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease. Respir Med. 2016;121:91\u20139. https:\/\/doi.org\/10.1016\/j.rmed.2016.10.019.","journal-title":"Respir Med"},{"issue":"8","key":"2542_CR11","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/mmy\/myaa024","volume":"58","author":"M Bateman","year":"2020","unstructured":"Bateman M, Oladele R, Kolls JK. Diagnosing Pneumocystis jirovecii pneumonia: a review of current methods and novel approaches. Med Mycol. 2020;58(8):1015\u201328. https:\/\/doi.org\/10.1093\/mmy\/myaa024.","journal-title":"Med Mycol"},{"issue":"12","key":"2542_CR12","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1093\/rheumatology\/keac288","volume":"61","author":"S Selickaja","year":"2022","unstructured":"Selickaja S, Galindo-Feria AS, Dani L, Mimori T, R\u00f6nnelid J, Holmqvist M, et al. ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis. Rheumatology (Oxford). 2022;61(12):4991\u20136. https:\/\/doi.org\/10.1093\/rheumatology\/keac288.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"2542_CR13","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","volume":"69","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, et al. 2017 european league against rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 2017;69(12):2271\u201382. https:\/\/doi.org\/10.1002\/art.40320.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"2542_CR14","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s10067-017-3794-3","volume":"36","author":"Y Li","year":"2017","unstructured":"Li Y, Zhou Y, Wang Q. Multiple values of (18)F-FDG PET\/CT in idiopathic inflammatory myopathy. Clin Rheumatol. 2017;36(10):2297\u2013305. https:\/\/doi.org\/10.1007\/s10067-017-3794-3.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"2542_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12890-021-01399-5","volume":"21","author":"X Zhan","year":"2021","unstructured":"Zhan X, Yan W, Wang Y, Li Q, Shi X, Gao Y, et al. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China. BMC Pulm Med. 2021;21(1):57. https:\/\/doi.org\/10.1186\/s12890-021-01399-5.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"2542_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11604-020-01030-3","volume":"39","author":"E Baratella","year":"2021","unstructured":"Baratella E, Marrocchio C, Cifaldi R, Santagiuliana M, Bozzato AM, Crivelli P, et al. Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study. Jpn J Radiol. 2021;39(1):40\u20136. https:\/\/doi.org\/10.1007\/s11604-020-01030-3.","journal-title":"Jpn J Radiol"},{"issue":"5","key":"2542_CR17","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/acr.22212","volume":"66","author":"AM Huber","year":"2014","unstructured":"Huber AM, Mamyrova G, Lachenbruch PA, Lee JA, Katz JD, Targoff IN, et al. Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken). 2014;66(5):732\u201340. https:\/\/doi.org\/10.1002\/acr.22212.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"2542_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1469-0691.2005.01337.x","volume":"12","author":"S Vidal","year":"2006","unstructured":"Vidal S, de la Horra C, Mart\u00edn J, Montes-Cano MA, Rodr\u00edguez E, Respaldiza N, et al. Pneumocystis jirovecii colonisation in patients with interstitial lung disease. Clin Microbiol Infect. 2006;12(3):231\u20135. https:\/\/doi.org\/10.1111\/j.1469-0691.2005.01337.x.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"2542_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11926-022-01072-8","volume":"24","author":"EK Joerns","year":"2022","unstructured":"Joerns EK, Adams TN, Sparks JA, Newton CA, Bermas B, Karp D, et al. Interstitial pneumonia with autoimmune features: what the rheumatologist Needs to Know. Curr Rheumatol Rep. 2022;24(6):213\u201326. https:\/\/doi.org\/10.1007\/s11926-022-01072-8.","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"2542_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.semarthrit.2020.11.009","volume":"51","author":"KY Sun","year":"2021","unstructured":"Sun KY, Fan Y, Wang YX, Zhong YJ, Wang GF. Prevalence of interstitial lung disease in polymyositis and dermatomyositis: a meta-analysis from 2000 to 2020. Semin Arthritis Rheum. 2021;51(1):175\u201391. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.11.009.","journal-title":"Semin Arthritis Rheum"},{"key":"2542_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s40064-015-1013-8","volume":"4","author":"S Ikeda","year":"2015","unstructured":"Ikeda S, Arita M, Misaki K, Mishima S, Takaiwa T, Nishiyama A, et al. Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study. Springerplus. 2015;4:240. https:\/\/doi.org\/10.1186\/s40064-015-1013-8.","journal-title":"Springerplus"},{"issue":"7","key":"2542_CR22","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","volume":"164","author":"WW Douglas","year":"2001","unstructured":"Douglas WW, Tazelaar HD, Hartman TE, Hartman RP, Decker PA, Schroeder DR, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med. 2001;164(7):1182\u20135. https:\/\/doi.org\/10.1164\/ajrccm.164.7.2103110.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"2542_CR23","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.011","volume":"13","author":"L Bodoki","year":"2014","unstructured":"Bodoki L, Nagy-Vincze M, Griger Z, Betteridge Z, Sz\u00f6ll\u0151si L, Dank\u00f3 K. Four dermatomyositis-specific autoantibodies-anti-TIF1\u03b3, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort. Autoimmun Rev. 2014;13(12):1211\u20139. https:\/\/doi.org\/10.1016\/j.autrev.2014.08.011.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"2542_CR24","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/1346-8138.15284","volume":"47","author":"N Ikeda","year":"2020","unstructured":"Ikeda N, Yamaguchi Y, Kanaoka M, Ototake Y, Akita A, Watanabe T, et al. Clinical significance of serum levels of anti-transcriptional intermediary factor 1-\u03b3 antibody in patients with dermatomyositis. J Dermatol. 2020;47(5):490\u20136. https:\/\/doi.org\/10.1111\/1346-8138.15284.","journal-title":"J Dermatol"},{"issue":"1","key":"2542_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/1346-8138.15128","volume":"47","author":"K Shimizu","year":"2020","unstructured":"Shimizu K, Kobayashi T, Kano M, Hamaguchi Y, Takehara K, Matsushita T. Anti-transcriptional intermediary factor 1-\u03b3 antibody as a biomarker in patients with dermatomyositis. J Dermatol. 2020;47(1):64\u20138. https:\/\/doi.org\/10.1111\/1346-8138.15128.","journal-title":"J Dermatol"},{"issue":"2","key":"2542_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massagu\u00e9","year":"2008","unstructured":"Massagu\u00e9 J. TGFbeta in Cancer. Cell. 2008;134(2):215\u201330. https:\/\/doi.org\/10.1016\/j.cell.2008.07.001.","journal-title":"Cell"},{"issue":"5","key":"2542_CR27","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.cell.2006.03.045","volume":"125","author":"W He","year":"2006","unstructured":"He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA, Massagu\u00e9 J. Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell. 2006;125(5):929\u201341. https:\/\/doi.org\/10.1016\/j.cell.2006.03.045.","journal-title":"Cell"},{"key":"2542_CR28","doi-asserted-by":"publisher","first-page":"6156","DOI":"10.1038\/ncomms7156","volume":"6","author":"J Xue","year":"2015","unstructured":"Xue J, Chen Y, Wu Y, Wang Z, Zhou A, Zhang S, et al. Tumour suppressor TRIM33 targets nuclear \u03b2-catenin degradation. Nat Commun. 2015;6:6156. https:\/\/doi.org\/10.1038\/ncomms7156.","journal-title":"Nat Commun"},{"issue":"11","key":"2542_CR29","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.3390\/ijms19113611","volume":"19","author":"A Saito","year":"2018","unstructured":"Saito A, Horie M, Micke P, Nagase T. The Role of TGF-\u03b2 Signaling in Lung Cancer Associated with Idiopathic Pulmonary Fibrosis. Int J Mol Sci. 2018;19(11):3611. https:\/\/doi.org\/10.3390\/ijms19113611.","journal-title":"Int J Mol Sci"},{"key":"2542_CR30","doi-asserted-by":"publisher","unstructured":"Boutanquoi PM, Burgy O, Beltramo G, Bellaye PS, Dondaine L, Marcion G, et al. TRIM33 prevents pulmonary fibrosis by impairing TGF-\u03b21 signalling. Eur Respir J. 2020;55(6). https:\/\/doi.org\/10.1183\/13993003.01346-2019.","DOI":"10.1183\/13993003.01346-2019"},{"issue":"5","key":"2542_CR31","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/s0002-9440(10)64282-4","volume":"162","author":"M Chilosi","year":"2003","unstructured":"Chilosi M, Poletti V, Zam\u00f2 A, Lestani M, Montagna L, Piccoli P, et al. Aberrant Wnt\/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol. 2003;162(5):1495\u2013502. https:\/\/doi.org\/10.1016\/s0002-9440(10)64282-4.","journal-title":"Am J Pathol"},{"issue":"1","key":"2542_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1172\/jci36940","volume":"119","author":"KK Kim","year":"2009","unstructured":"Kim KK, Wei Y, Szekeres C, Kugler MC, Wolters PJ, Hill ML, et al. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest. 2009;119(1):213\u201324. https:\/\/doi.org\/10.1172\/jci36940.","journal-title":"J Clin Invest"},{"issue":"2","key":"2542_CR33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/rheumatology\/kex413","volume":"57","author":"I Pinal-Fernandez","year":"2018","unstructured":"Pinal-Fernandez I, Ferrer-Fabregas B, Trallero-Araguas E, Balada E, Mart\u00ednez MA, Milisenda JC, et al. Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis. Rheumatology (Oxford). 2018;57(2):388\u201396. https:\/\/doi.org\/10.1093\/rheumatology\/kex413.","journal-title":"Rheumatology (Oxford)"},{"key":"2542_CR34","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3389\/fimmu.2017.00992","volume":"8","author":"A Aussy","year":"2017","unstructured":"Aussy A, Boyer O, Cordel N. Dermatomyositis and immune-mediated necrotizing myopathies: a window on autoimmunity and cancer. Front Immunol. 2017;8:992. https:\/\/doi.org\/10.3389\/fimmu.2017.00992.","journal-title":"Front Immunol"},{"issue":"9","key":"2542_CR35","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1007\/s10067-021-05660-4","volume":"40","author":"HC Hsu","year":"2021","unstructured":"Hsu HC, Chang YS, Hou TY, Chen LF, Hu LF, Lin TM, et al. Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study. Clin Rheumatol. 2021;40(9):3755\u201363. https:\/\/doi.org\/10.1007\/s10067-021-05660-4.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"2542_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/rheumatology\/kez252","volume":"59","author":"MGL Wilkinson","year":"2020","unstructured":"Wilkinson MGL, Radziszewska A, Wincup C, Ioannou Y, Isenberg DA, Manson JJ, et al. Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathies. Rheumatology (Oxford). 2020;59(1):194\u2013204. https:\/\/doi.org\/10.1093\/rheumatology\/kez252.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"2542_CR37","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1084\/jem.20090127","volume":"206","author":"JM Doisne","year":"2009","unstructured":"Doisne JM, Bartholin L, Yan KP, Garcia CN, Duarte N, Le Luduec JB, et al. iNKT cell development is orchestrated by different branches of TGF-beta signaling. J Exp Med. 2009;206(6):1365\u201378. https:\/\/doi.org\/10.1084\/jem.20090127.","journal-title":"J Exp Med"},{"issue":"9","key":"2542_CR38","doi-asserted-by":"publisher","first-page":"1023.e1","DOI":"10.1016\/j.amjmed.2015.03.032","volume":"128","author":"JL Lee","year":"2015","unstructured":"Lee JL, Oh ES, Lee RW, Finucane TE. Serum albumin and prealbumin in calorically restricted, nondiseased individuals: a systematic review. Am J Med. 2015;128(9):1023.e1-22. https:\/\/doi.org\/10.1016\/j.amjmed.2015.03.032.","journal-title":"Am J Med"},{"key":"2542_CR39","doi-asserted-by":"publisher","first-page":"826268","DOI":"10.3389\/fimmu.2022.826268","volume":"13","author":"H Michael","year":"2022","unstructured":"Michael H, Amimo JO, Rajashekara G, Saif LJ, Vlasova AN. Mechanisms of kwashiorkor-associated immune suppression: insights from human, mouse, and pig studies. Front Immunol. 2022;13:826268. https:\/\/doi.org\/10.3389\/fimmu.2022.826268.","journal-title":"Front Immunol"},{"issue":"12","key":"2542_CR40","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1097\/00005768-199812000-00002","volume":"30","author":"CB Scanga","year":"1998","unstructured":"Scanga CB, Verde TJ, Paolone AM, Andersen RE, Wadden TA. Effects of weight loss and exercise training on natural killer cell activity in obese women. Med Sci Sports Exerc. 1998;30(12):1666\u201371. https:\/\/doi.org\/10.1097\/00005768-199812000-00002.","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"2542_CR41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1183\/09031936.03.00026703","volume":"22","author":"V Cottin","year":"2003","unstructured":"Cottin V, Thivolet-B\u00e9jui F, Reynaud-Gaubert M, Cadranel J, Delaval P, Ternamian PJ, et al. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J. 2003;22(2):245\u201350. https:\/\/doi.org\/10.1183\/09031936.03.00026703.","journal-title":"Eur Respir J"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02542-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02542-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02542-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T15:03:27Z","timestamp":1688655807000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02542-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2542"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02542-0","relation":{},"ISSN":["1471-2466"],"issn-type":[{"type":"electronic","value":"1471-2466"}],"subject":[],"published":{"date-parts":[[2023,7,6]]},"assertion":[{"value":"20 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Any involvement of human participants, materials, or data complied with the Declaration of Helsinki. We have received approval for using case information and materials from the Medical Ethics Committee of Qilu Hospital, Shandong University. In addition, we have received written informed consent from the patient's family.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of identifying images or other personal or clinical details was obtained from the patient \u2018s family.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}